Cogent Biosciences's total assets for Q3 2025 were $425.93M, an increase of 54.99% from the previous quarter. COGT total liabilities were $123.47M for the fiscal quarter, a 3.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.